journal cover

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

American Journal of Hematology

Dec 4, 2019

Paul J HampelSameer A Parikh

Abstract

No abstract listed.

Mentioned in this Paper

Chronic Lymphocytic Leukemia
Disease Progression
Ibrutinib
Combination Drug Therapy
3
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

American Journal of Hematology

Dec 4, 2019

Paul J HampelSameer A Parikh

PMID: 31788844

DOI: 10.1002/ajh.25690

Abstract

No abstract listed.

Mentioned in this Paper

Chronic Lymphocytic Leukemia
Disease Progression
Ibrutinib
Combination Drug Therapy
3
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/addition-of-venetoclax-at-time-of-progression-in/31788844